CALPOL

This brand name is authorized in Cyprus, Ireland, Malta, Poland, Singapore, South Africa, Turkey, UK.

Active ingredients

The drug CALPOL contains one active pharmaceutical ingredient (API):

1	Paracetamol UNII 362O9ITL9D - ACETAMINOPHEN
	Paracetamol is a medication used to treat pain and fever. It does appear to selectively inhibit COX activities in the brain, which may contribute to its ability to treat fever and pain.
	Read more about Paracetamol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
CALPOL SIX PLUS Orodispersible tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
CALPOL INFANT Oral suspension	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N02BE01	Paracetamol	N Nervous system → N02 Analgesics → N02B Other analgesics and antipyretics → N02BE Anilides
Discover more medicines within N02BE01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
GB	Medicines & Healthcare Products Regulatory Agency	115220, 120541, 130933, 134991, 152415, 154230, 18655, 278481, 27902, 27903, 90922, 91004, 95029, 95030, 98312
MT	Medicines Authority	MA192/03701, MA192/03702, MA192/03703
PL	Rejestru Produktów Leczniczych	100076388
SG	Health Sciences Authority	06062P
TR	İlaç ve Tıbbi Cihaz Kurumu	8699522705009, 8699522705160
ZA	Health Products Regulatory Authority	44/2.7/0321, B/2.7/767